Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Riviciclib |
Trade Name | |
Synonyms | P276-00|P276 |
Drug Descriptions |
Riviciclib (P276-00) is an inhibitor of CDK1, CDK4, and CDK9, which may induce cell cycle arrest and apoptosis in cancer cells (PMID: 17363486, PMID: 32175313). |
DrugClasses | CDK1 Inhibitor 13 CDK4 Inhibitor 17 CDK9 Inhibitor 21 |
CAS Registry Number | 920113-03-7 |
NCIT ID | C64762 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Riviciclib | Riviciclib | 0 | 0 |